Refractory Ovarian Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB14547Chloride ion0Recruiting1
DB00515Cisplatin0Recruiting1
DB00694Daunorubicin0Recruiting1
DB00997Doxorubicin0Recruiting1
DB12257Platinum0Recruiting1
DB09499Thiosulfuric acid0Recruiting1
DB00041Aldesleukin1Recruiting1
DB01373Calcium1Recruiting1
DB00888Mechlorethamine1Recruiting1
DB01229Paclitaxel1Recruiting1
DB15366SOR-C131Recruiting1
DB00135Tyrosine1Recruiting1
DB11714Durvalumab1 / 2Recruiting1
DB00041Aldesleukin2Recruiting1
DB14809Anetumab ravtansine2Recruiting1
DB00112Bevacizumab2Recruiting1
DB00531Cyclophosphamide2Recruiting2
DB11714Durvalumab2Recruiting1
DB01073Fludarabine2Recruiting2
DB14865Human interleukin-22Recruiting1
DB11740MK-17752Recruiting1
DB14844ONC-2012Not Yet Recruiting1
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Not Yet Recruiting1
DB01229Paclitaxel2Recruiting1
DB15389Teceleukin2Recruiting1
DB11771Tremelimumab2Recruiting1